Related Experiment Video

Updated: Apr 12, 2026

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

19.4K

Exon skipping therapy for Duchenne muscular dystrophy

Ryszard Kole1, Arthur M Krieg2

  • 1Sarepta Therapeutics Inc., Cambridge, MA, USA.

Advanced Drug Delivery Reviews
|May 19, 2015
PubMed

Insights

Duchenne muscular dystrophy (DMD) is a genetic disorder caused by dystrophin gene deletions. Exon skipping therapy aims to restore the dystrophin protein, offering a potential treatment for DMD patients.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neuromuscular Disorders

Background:

  • Duchenne muscular dystrophy (DMD) results from internal deletions in the dystrophin gene.
  • These deletions disrupt the reading frame, leading to a lack of functional dystrophin protein.
  • Dystrophin is crucial for maintaining muscle cell membrane integrity, and its absence causes progressive muscle degeneration.

Purpose of the Study:

  • To investigate the therapeutic potential of exon skipping for Duchenne muscular dystrophy.
  • To explore the restoration of dystrophin protein production through pre-mRNA modification.

Main Methods:

  • Utilizing exon skipping in dystrophin pre-mRNA to correct reading frame abrogation.
  • Developing oligonucleotide drugs to induce specific exon skipping events.

Main Results:

  • The exon skipping method successfully restores the reading frame in the dystrophin gene.
  • This restoration enables the production of internally deleted but functional dystrophin protein.

Conclusions:

  • Exon skipping is a promising strategy for treating Duchenne muscular dystrophy.
  • Oligonucleotide-based exon skipping drugs are in advanced clinical trials for DMD.
Keywords:
Clinical trialsDrisapersenEteplirsenExon skippingRNA splicingRNA therapeutics

More Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.5K
Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived Cells06:20

Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived Cells

Published on: May 7, 2020

7.5K

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.6K
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
4.3K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
636
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.2K
Gene Therapy00:59

Gene Therapy

4.8K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
27.1K